Oric Pharmaceuticals Inc
(ORIC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,974 | -25,011 | -100,697 | -72,367 | -46,889 |
| Depreciation Amortization | -3,990 | -1,966 | -5,137 | -3,277 | -1,612 |
| Other Working Capital | -4,801 | -8,167 | 4,898 | 2,914 | -720 |
| Other Operating Activity | 9,954 | 4,958 | 15,248 | 11,312 | 7,448 |
| Operating Cash Flow | $-55,811 | $-30,186 | $-85,688 | $-61,418 | $-41,773 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -43,037 | -61,650 | -42,554 | -63,574 | -5,820 |
| PPE Investments | -551 | -218 | -849 | -792 | -715 |
| Investing Cash Flow | $-43,588 | $-61,868 | $-43,403 | $-64,366 | $-6,535 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 126,014 | 125,198 | 85,885 | 85,431 | 85,400 |
| Other Financing Activity | -168 | -168 | -227 | -226 | -226 |
| Financing Cash Flow | $125,846 | $125,030 | $85,658 | $85,205 | $85,174 |
| Beginning Cash Position | 23,875 | 23,875 | 67,308 | 67,308 | 67,308 |
| End Cash Position | 50,322 | 56,851 | 23,875 | 26,729 | 104,174 |
| Net Cash Flow | $26,447 | $32,976 | $-43,433 | $-40,579 | $36,866 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,811 | -30,186 | -85,688 | -61,418 | -41,773 |
| Capital Expenditure | -551 | -218 | -849 | -792 | -715 |
| Free Cash Flow | -56,362 | -30,404 | -86,537 | -62,210 | -42,488 |